Form Type: 4

SEC EDGAR Link
Acccession Number:0001209191-19-029970
Date:2019-05-13
Issuer: FLEXION THERAPEUTICS INC (FLXN)
Original Submission Date:

Reporting Person:

ARKOWITZ DAVID
C/O FLEXION THERAPEUTICS, INC.
10 MALL ROAD, SUITE 301 BURLINGTON, MA 01803

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2019-05-13 P 4,000 a $11.99 86,924 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 the weighted average purchase price for the transaction reported was $11.99, and the range of prices were between $11.9877 and $11.9879. upon request by the sec staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price will be provided.

Elevate your investments